• 제목/요약/키워드: Negative therapy

검색결과 1,070건 처리시간 0.026초

사람 양수에서 호흡기세포의 분리 (Isolation and Identification of Respiratory Cells from Human Amniotic Fluid)

  • 김은정;박용원;김영한;김유선;오정탁
    • Advances in pediatric surgery
    • /
    • 제15권1호
    • /
    • pp.1-10
    • /
    • 2009
  • 최근에 양수에 존재하는 세포들은 다양한 세포분화의 능력을 가지고 있으며 세포 치료와 조직공학의 세포원으로서의 가능성이 높다는 연구 결과가 많이 보고되고 있다. 그러나 양수 내에 어떤 종류의 세포가 정상적으로 존재하는 지에 대해서는 제한적으로 알려져 있다. 본 연구에서는 사람의 양수 내에 호흡기세포를 분리 배양하는 것을 목표로 하였다. 임신 17주에서 20주 사이의 산모 10명에서 각각 5 mL의 양수를 획득하여 small airway growth medium (SAGM) 배양액에서 계대 배양을 시행하였으며 type II alveolar cells이 존재하는 지에 대하여 면역형광염색 및 RT-PCR을 시행하였다. 배양된 세포는 광학현미경 상 상피세포와 유사한 다면체의 모양이었으며 계대 배양 시에 변화 없이 동일한 형체를 보였다. 배양된 세포는 면역형광염색 상 type II alveolar cell의 특이표지자인 surfactant protein C (SPC) 및 TTF-1 protein에 대해서는 양성이었으나 CD 31 및 vimentin에 대해서는 음성이었으며, RT-PCR 상 SPC mRNA 가 발현되었다. 이상의 결과로 사람의 양수를 특이 배양액에 배양하면 호흡기세포를 분리, 확인할 수 있음을 알았으며 이러한 결과가 향후 양수세포의 추가적인 연구에 활용될 수 있다고 생각된다.

  • PDF

ADHD 아동을 둔 어머니들의 ADHD 치료 및 서비스 경험에 관한 연구 (Mothers' Experience of Treatment Services for Attention Deficit Hyperactivity Disorder)

  • 최말옥
    • 한국사회복지학
    • /
    • 제68권2호
    • /
    • pp.161-184
    • /
    • 2016
  • 본 연구는 ADHD 아동을 양육하는 어머니들의 체험을 통한 ADHD 아동에 대한 치료와 서비스 본질 의미를 탐구하고자 하였다. 본질을 탐색하기 위해 ADHD 아동에게 실시한 치료와 서비스의 경험을 Giorgi 4단계를 토대로 단계별 치료와 서비스 경험의 의미와 정보 채널의 과정을 연구문제 내용으로 기술하였다. 연구문제는 ADHD 아동 어머니들이 경험한 ADHD 치료 및 서비스 경험의 실태는 무엇인가?, ADHD 아동 어머니들이 경험한 ADHD 치료 및 서비스의 본질적 의미는 무엇인가? ADHD 아동 어머니들이 경험한 ADHD 치료 및 서비스 경험의 구조는 어떠한가?로 구성되었다. 이를 위해 2014년 6월부터 전화면접을 통한 접촉을 시작하였으며, 인터뷰는 2014년 12월부터 2015년 2월까지 실시되었다. 13명의 ADHD 아동 어머니를 대상으로 2~3회에 걸쳐 현상학적 연구로 진행되었다. 그 결과 ADHD 아동 어머니들이 경험한 ADHD 치료 및 서비스 경험의 본질적 의미를 통한 질적 구조는 '내가 변해야 우리 아이가 산다'는 것으로 인지의 변화를 가져온 '인식변화를 위한 동행과정'이었다. 이러한 과정은 '무지와 혼란 속에서 자기결정의 부재'를 가져온 경험을 통해 '지각한 현실과 불안에 대처하며 변화에의 욕구'를 가진 후 '변화를 시도하지만 아직 남은 미결의 과제'를 지닌 채 '긍정적 변화의 주체로' 맞서 나아가는 과정이었다. 이 연구결과를 통해 병합치료의 필요성과 치료를 지속하는데 있어 부모의 올바른 인식에 의한 치료 참여는 주요한 변인이 된다는 것을 알 수 있었다. 아울러 아동의 변화를 위한 어머니의 변화가 중요하지만 삶에 대한 어머니의 태도가 긍정적으로 변화될 때만이 이루어질 수 있는, 어머니의 인지의 변화 과정이었다는 것이다.

  • PDF

조현병 환자에서 장기지속형 항정신병 주사제 팔리페리돈 팔미테이트의 효능과 안전 : 24주 개방형 연구 (Safety and Effectiveness of Long Acting Injectable Antipsychotic Paliperidone Palmitate Treatment in Schizophrenics : A 24-Week Open-Label Study)

  • 강현구;함웅;손인기;백인호
    • 생물정신의학
    • /
    • 제20권3호
    • /
    • pp.111-117
    • /
    • 2013
  • Objectives We investigated the effectiveness and safety when treated in schizophrenics with paliperidone palmitate, a long acting injectable antipsychotic. Methods This was a 24-week open-label study, performed at one center in Korea. The eligible patients with schizophrenia diagnosed by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria were enrolled. Patients received long-acting paliperidone palmitate injection (234 mg, baseline; 156 mg, week 1 ; then once 4 weeks flexible dosing). Effectiveness assessments were measured by the Positive and Negative Syndrome Scale (PANSS), The Clinical Global Impression Severity Scale (CGI-S), The Personal and Social Performance (PSP) at baseline, week 1, every 4 weeks untill 24 weeks or endpoint. Safety assessments were measured by The Extrapyramidal Symptom Rating Scale (ESRS), body weight (BW) and incidence of adverse events. Oral antipsychotics were stopped or tapered off within next 14 days. Results Of 20 patients recruited, 9 patients (45%) completed the study. Paliperidone palmitate produced a significant improvement in PANSS total score from baseline to endpoint. The response rate was 75% [mean change (${\pm}SD$) $-25.9{\pm}14.4$, all p < 0.001]. The CGI-S and PSP total scores significantly improved during 24 weeks (All p < 0.001). Eighty percent of patients reported adverse events and most common adverse events (${\geq}10%$) in paliperidone palmitate were anticholinergic adverse event, extrapyramidal symptoms, weight gain, akathisia, insomnia, headache, agitation, anxiety and GI trouble. ESRS score is not statistically significant, but tends to get better at the end of the study when compared to baseline. Conclusions Our study results demonstrated maintained effectiveness and safety of paliperidone palmitate treatment in schizophrenics. And provides both clinicians and patients with a new choice of treatment that can improve the outcome of long term therapy. Their potential effectiveness and safety should be better addressed by future randomized-controlled trials.

양식업에서 바실러스 폴리퍼멘티쿠스 콩발효물의 상업적 응용 (Industrial Application for Aquaculture of Fermented Soybean with Bacillus polyfermenticus SCD)

  • 이진영;김강민;강재선
    • 한국해양바이오학회지
    • /
    • 제2권1호
    • /
    • pp.48-54
    • /
    • 2007
  • 바실러스 폴리퍼멘티쿠스 에스씨디는 활성아포를 형성하여 장까지 도달하는 특성 때문에 장기적인 장 질환 치료에 사용되어져 왔다. 뿐만 아니라 강력한 항생물질을 생산하는 장점을 가지고 있다. 현 연구는 바실러스 폴리퍼멘티쿠스 에스씨디와 콩을 함께 발효시킨 것 (BPFS)과 그것의 생균제 특성에 관하여 조사하였다. 바실러스 폴리퍼멘티쿠스 에스씨디는 와 BPFS는 병원성 그람양성 (스트렙토코커스 파라우베리스, 스트렙토코커스 이니에, 락도코커스 가르비에), 그람 음성 (플렉시박터 트렉튜오서스, 비브리오 하베이, 비브리오 불니피쿠스, 비브리오 오다리), 곰팡이 (아스파라질러스 니거, 아스파라질러스 오리자에)에 이르기까지 넓은 범위의 항균성을 가졌다. BPFS에 의한 생존율 증가와 부영양화로 인한 수질오염의 정화작용을 관찰하기 위해서 통영 앞바다 양식장에서 조피볼락을 사용해서 현장 실험을 하였다. 그 결과, 해양 병원성 유해 박테리아에 노출시키고 일반 사료만 복용시킨 군에서는 99%의 폐사율을 보였으나, BPFS를 사료와 함께 복용시킨 군에서는 먹이 유인효과에 의한 성장률의 증가와 부영양화에 의한 수질오염을 정화하는 작용이 관찰되었다. 따라서 BPFS는 양식업에서 항생물질 대체제, 사료첨가제, 부영양화에 의한 정화제로서 개발하여 산업화하기 용이한 후보물질이라고 사료된다.

  • PDF

Expression of ERCC1, RRM1 and LRP in Non-small Cell Lung Cancers and their Influence on Chemotherapeutic Efficacy of Gemcitabine Concomitant with Nedaplatin

  • Qiu, Zhen-Qin;Zhao, Kun
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권17호
    • /
    • pp.7303-7307
    • /
    • 2014
  • Objective: To explore the clinical efficacy of gemcitabine concomitant with nedaplatin and drug resistance in the treatment of non-small cell lung cancer (NSCLC) and associated molecular predicators. Materials and Methods: A total of 68 patients diagnosed with NSCLC by histology served as the study objects and were randomly divided into an observation group treated with gemcitabine concomitant with nedaplatin and a control group with cisplatin concomitant with gemcitabine, 34 cases for each group. Short-term and long-term efficacies, adverse responses as well as the expression of nucleotide excision repair cross complementing 1 (ERCC1), ribonucleotide reductase subunit M1 (RRM1) and lung resistance-related protein (LRP) in NSCLC tissues in both groups were assessed. Results: The short-term objective response rate (ORR) and disease control rate (DCR) were 35.3% (12/34) and 76.5% (26/34) in the observation group and 38.2% (13/34) and 85.3% (29/34) in the control group, respectively, the differences not being statistically significant. The time to progression (TTP) in both groups were 1~12 months, while the median TTP was 135 d and 144 d, respectively. Though the survival was slightly higher in the control group, there were no significant differences in TTP and survival time. The rates of decreased hemoglobin, vomiting and nausea as well as renal toxicity were evidently lower in the observation group, while other adverse responses demonstrated no significant difference. The positive expression rates of ERCC1, RRM1 and LRP were 47.1% (16/34), 61.8% (21/34) and 64.7% (22/34) in the observation group, respectively. Compared with negative ERCC1 expression, ORR had decreasing trend and the overall survival time (OS) decreased significantly in patients with positive ERCC1 expression, which were markedly decreased by the positive expressions of RRM1 and LRP. Conclusions: Gemcitabine concomitant with nedaplatin has significant effects in the treatment of NSCLC, with an adverse response rate obviously lower than for cisplatin concomitant with gemcitabine, suggesting that wider use in the clinic is warranted. Additionally, the positive expressions of ERCC1, RRM1 and LRP may increase patient drug resistance, so they can be applied as the chemotherapeutic predicators to guide individualized therapy of NSCLC patients.

FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer

  • Kim, Gi-Won;Kim, Yeon-Sil;Han, Eun-Ji;Yoo, Ie-Ryung;Song, Jin-Ho;Lee, Sang-Nam;Lee, Jong-Hoon;Choi, Byung-Oak;Jang, Hong-Seok;Yoon, Sei-Chul
    • Radiation Oncology Journal
    • /
    • 제29권4호
    • /
    • pp.243-251
    • /
    • 2011
  • Purpose: To evaluate the prognostic value of metabolic tumor volume (MTV) and maximum standardized uptake value (SUVmax) on initial positron emission tomography-computed tomography (PET-CT) and investigate the clinical value of SUVmax for early detection of locoregional recurrent disease after postoperative radiotherapy in patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Materials and Methods: A total of 100 patients with locally advanced HNSCC received primary tumor excision and neck dissection followed by adjuvant radiotherapy with or without chemotherapy. The MTV and SUVmax were measured from primary sites and neck nodes. The prognostic value of MTV and SUVmax were assessed using initial staging PET/CT (study A). Follow-up PET/CT scan available after postoperative concurrent chemoradiotherapy or radiotherapy were evaluated for the SUVmax value and correlated with locoregional recurrence (study B). A receiver operating characteristic (ROC) curve analysis was used to define a threshold value of SUVmax with the highest accuracy for recurrent disease assessment. Results: High MTV (>41 mL) is negative prognostic factor for disease free survival (p = 0.041). Postradiation SUVmax was significantly correlated with locoregional recurrence (hazard ratio, 1.812; 95% confidence interval, 1.361 to 2.413; P < 0.001). A cutoff value of 5.38 from follow-up PET/CT was identified as having maximal accuracy for detecting locoregional recurrence by ROC analysis. Conclusion: MTV at staging work-up was significantly associated with disease free survival. The SUVmax value from follow-up PET/CT showed high diagnostic accuracy for the detection of locoregional recurrence in postoperatively irradiated HNSCC.

Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors

  • Moazzezy, Neda;Ebrahimi, Fatemeh;Sisakht, Mahsa Mollapour;Yahyazadeh, Hossein;Bouzari, Saeid;Oloomi, Mana
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권1호
    • /
    • pp.249-254
    • /
    • 2016
  • Molecular detection methods such as RT-PCR for detecting breast cancer-associated gene expression in the peripheral blood have the potential to modify breast cancer (BC) staging and therapy. In this regard, we evaluated the potential of erb-B2 molecular marker in BC detection and analyzed the expression of erb-B2 mRNA in the peripheral blood and fresh tissue samples of 50 pretreated female BC patients and 50 healthy females by reverse transcription-PCR (RT-PCR) method. We also assessed the correlation of erb-B2 mRNA marker positivity in peripheral blood and tumor tissue samples with clinical and pathological factors in BC patients in order to evaluate its prognostic value. It was shown that there is a significant difference between healthy females and BC patients with expression of the erb-B2 molecular marker (p<0.01). A significant difference between the expression of erb-B2 in the peripheral blood and tissue samples of BC patients (p<0.01) and the frequency of circulating erb-B2 mRNA expression in peripheral blood and in tissue was detected by RT-PCR. No correlation was found between erb-B2 mRNA expression in blood or tumor tissue samples and lymph node, tumor grade, tumor stage, tumor size, patient's age, ki67, estrogen receptor (ER), progesterone receptor (PGR), P53, and HER-2 status. However, in a small subset of 31 BC patients we found that expression of erb-B2 in peripheral blood or in both peripheral blood and tumor tissue was directly correlated with lympho-vascular invasion and perineural invasion as poor prognostic features. The highest rates of erb-B2 expression in peripheral blood or tumor tissue were in the ER and PR negative and HER-2 positive group. This study suggests that the application of the RT-PCR and immunohistochemical methods for erb-B2 molecular marker detection would provide a higher detection rate, especially in early stage BC.

Plan Dose Evaluation of Three Dimensional Conformal Radiotherapy Planning (3D-CRT) of Nasopharyngeal Carcinoma (NPC): Experience of a Tertiary Care University Hospital in Pakistan

  • Abbasi, Ahmed Nadeem;Hafiz, Asim;Ali, Nasir;Khan, Khurshid Ahmed
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권10호
    • /
    • pp.5989-5993
    • /
    • 2013
  • Background: Radiation therapy is the mainstay of treatment for nasopharyngeal carcinoma. Importance of tumor coverage and challenges posed by its unique and critical location are well evident. Therefore we aimed to evaluate our radiation treatment plan through dose volume histograms (DVHs) to find planning target volume (PTV) dose coverage and factors affecting it. Materials and Methods: This retrospective study covered 45 histologically proven nasopharyngeal cancer patients who were treated with definitive 3D-CRT and chemotherapy between Feb 2006 to March 2013 at the Department of Oncology, Section Radiation Oncology, Aga Khan University Hospital, Karachi, Pakistan. DVH was evaluated to find numbers of shrinking field (phases), PTV volume in different phases and its coverage by the 95% isodose lines, along with influencing factors. Results: There were 36 males (80%) and 9 females (20%) in the age range of 12-84 years. Stage IVA (46.7%) was the most common stage followed by stage III (31.1). Eighty six point six-percent received induction, 95.5% received concurrent and 22.2% received adjuvant chemotherapy. The prescribed median radiation dose was 70Gy to primary, 60Gy to clinically positive neck nodes and 50Gy to clinically negative neck regions. Mean dose to spinal cord was 44.2Gy and to optic chiasma was 52Gy. Thirty seven point eight-percent patients completed their treatment in three phases while 62.2% required four to five phases. Mean volume for PTV3 was $247.8cm^3$ (50-644.3), PTV4 $173.8cm^3$ (26.5-345.1) and PTV5 $119.6cm^3$ (18.9-246.1) and PTV volume coverage by 95% isodose lines were 74.4%, 85.7% and 100% respectively. Advanced T stage, intracranial extension and tumor volume > $200cm^3$ were found to be important factors associated with decreased PTV coverage by 95% isodose line. Conclusions: 3D CRT results in adequate PTV dose coverage by 95% isodose line. However advanced T stage, intracranial extension and large target volume require more advanced techniques like IMRT for appropriate PTV coverage.

Overexpression of the MUC1 Gene in Iranian Women with Breast Cancer Micrometastasis

  • Mansouri, Neda;Movafagh, Abolfazl;Soleimani, Shahrzad;Taheri, Mohammad;Hashemi, Mehrdad;Pour, Atefeh Heidary;Shargh, Shohreh Alizadeh;Mosavi-Jarahi, Alireza;Sasaninejad, Zahra;Zham, Hanieh;Hajian, Parastoo;Moradi, Hossein Allah;Mirzaei, Hamid Reza;Fardmanesh, Hedieh;Ohadi, Mina
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권sup3호
    • /
    • pp.275-278
    • /
    • 2016
  • The membrane epithelial mucin MUC1 is expressed at the luminal surface of most simple epithelial cells, but expression is greatly increased in most breast cancers. The aims of present study were to investigate expression of the MUC1 gene and interactive affects in metastases. Whole cell RNA isolation from 50 sentinel lymph nodes (SNLs) of breast cancer patients was performed using reverse transcription and real-time PCR. All patients were diagnosed with breast cancer and without metastasis, confirmed by IHC staining. The evaluation of tumor and normal samples for expression of MUC1 gene, the results were 49.1% non-expressive and 45.3% expression (Student t, p = 0.03). Also in comparison of normal breast tissue and breast cancer SLN for MUC1 gene, MUC1 negative SLNs were 75.0% (18 samples) and MUC1 positive samples were 25.0% (6 samples). Over-expression of MUC1 gene may offer a target for therapy related to progression and metastasis in women with breast cancer.

한국판 음악 기능 척도의 타당화와 정서적 적응과의 관계 (Validation of RESPECT-Music With a Korean Sample)

  • 이정윤;김민희
    • 인간행동과 음악연구
    • /
    • 제14권2호
    • /
    • pp.45-70
    • /
    • 2017
  • 본 연구에서는 음악을 개인적, 사회적, 문화적 목적으로 사용하는 개인의 성향을 측정하기 위해 음악 기능 척도(RESPECT-Music)를 한국어로 번안 및 타당화하고, 정서적 적응과의 관계를 탐색하였다. 대학생 212명으로 구성된 표본 A를 대상으로 탐색적 요인분석을 실시하였고, 대학생 296명으로 구성된 표본 B를 대상으로 확인적 요인분석과 신뢰도 분석 및 정서적 적응 변인과의 상관분석을 하였다. 탐색적 요인분석 결과 한국어로 번안된 음악 기능 척도는 원 척도와 동일하게 배경 음악, 가치 발달, 집중 향상, 춤 유도, 가족과의 유대, 문화적 정체성 반영, 정치적 태도 표현, 스트레스 해소, 정서 전달, 친구와의 유대의 10요인으로 구성되어 있음을 확인하였다. 확인적 요인분석 결과 10요인 35문항 모형의 적합도가 적절하였고, 문항 신뢰도도 양호하였다. 정서적 적응 변인들과 상관분석을 실시한 결과, 음악 기능 척도는 정적 정서, 재해석 정서조절 방략, 정서개선 신념과 유의한 정적 상관을 보여 대체적으로 정서적 적응과 연관 있는 것으로 나타났다. 10개 하위요인 중 춤 유도 기능이 정서적 적응과 가장 뚜렷한 연관성을 나타냈으며 정치적 태도 표현 기능은 예외적으로 정서적 적응과 상반되는 결과를 나타냈다. 연구 결과를 음악 기능의 세 차원으로 설명하면, 음악을 개인적, 사회적 목적으로 사용할수록 정서적 적응 수준이 높았고, 문화적 목적으로 사용하는 것은 정서적 적응과의 관련성이 낮았다.